Progesterone Injection USP — Class II drug recall D-0186-2025
Ongoing recall by Eugia US LLC, reported 2025-01-15, distributed nationwide. Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
| Recall number | D-0186-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eugia US LLC, East Windsor, NJ, United States |
| Recall initiated | 2024-12-27 |
| Classified | 2025-01-07 |
| Reported by FDA | 2025-01-15 |
| Distributed | Nationwide (US) |
| Reason classes | foreign material, specification failure |
| NDC | 55150-0306, 55150-0306-10 |
| Lot numbers | 1PR24010 |
| Expiration dates | 2027-02-28 |
Product
Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10
Reason for recall
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0186-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.